Paolo Feltracco
Research Subjects
Research Interests
Paolo Feltracco has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
C. Ori
Dipartimento di Medicina, UOC Anestesia e Terapia Intensiva, Università degli Studi di Padova, Padova, Italy
16 shared publicationsCarlo Ori
Department of Medicine UO Anesthesia and Intensive Care, Padova University Hospital, Padova, Italy
15 shared publicationsS. Barbieri
Department of Medicine, UO Anesthesia and Intensive Care, Padua University, Padua, Italy
13 shared publicationsM. Milevoj
Dipartimento di Medicina, UOC Anestesia e Terapia Intensiva, Università degli Studi di Padova, Padova, Italy
12 shared publicationsStefania Barbieri
Department of Medicine, UO Anesthesia and Intensive Care, University of Padua, Italy
11 shared publicationsE. Serra
8 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in Transplantation Reviews
- Vol. 33 (4) , 219-230
Early circulatory complications in liver transplant patients
- 1 October 2019
- Published by Elsevier in Transplantation Reviews
- Vol. 33 (4) , 219-230
Early circulatory complications in liver transplant patients
- 1 January 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (1) , 179-183
Risk Factors for Early Mortality in Liver Transplant Patients
- 1 January 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (1) , 179-183
Risk Factors for Early Mortality in Liver Transplant Patients
- 2 December 2017
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 31 (5)
Perioperative benefit and outcome of thoracic epidural in esophageal surgery: a clinical review
Surgery for esophageal cancer is a highly stressful and painful procedure, and a significant amount of analgesics may be required to eliminate perioperative pain and blunt the stress response to surgery. Proper management of postoperative pain has invariably been shown to reduce the incidence of postoperative complications and accelerate recovery. Neuraxial analgesic techniques after major thoracic and upper abdominal surgery have long been established to reduce respiratory, cardiovascular, metabolic, inflammatory, and neurohormonal complications. The aim of this review is to evaluate and discuss the relevant clinical benefits and outcome, as well as the possibilities and limits of thoracic epidural anesthesia/analgesia (TEA) in the setting of esophageal resections. A comprehensive search of original articles was conducted investigating relevant literature on MEDLINE, Cochrane reviews, Google Scholar, PubMed, and EMBASE from 1985 to July2017. The relationship between TEA and important endpoints such as the quality of postoperative pain control, postoperative respiratory complications, surgical stress-induced immunosuppression, the overall postoperative morbidity, length of hospital stay, and major outcomes has been explored and reported. TEA has proven to enable patients to mobilize faster, cooperate comfortably with respiratory physiotherapists and achieve satisfactory postoperative lung functions more rapidly. The superior analgesia provided by thoracic epidurals compared to that from parenteral opioids may decrease the incidence of ineffective cough, atelectasis and pulmonary infections, while the associated sympathetic block has been shown to enhance bowel blood flow, prevent reductions in gastric conduit perfusion, and reduce the duration of ileus. Epidural anesthesia/analgesia is still commonly used for major ‘open’ esophageal surgery, and the recognized advantages in this setting are soundly established, in particular as regards the early recovery from anesthesia, the quality of postoperative pain control, and the significantly shorter duration of postoperative mechanical ventilation. However, this technique requires specific technical skills for an optimal conduction and is not devoid of risks, complications, and failures.
- 2 December 2017
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 31 (5)
Perioperative benefit and outcome of thoracic epidural in esophageal surgery: a clinical review
Surgery for esophageal cancer is a highly stressful and painful procedure, and a significant amount of analgesics may be required to eliminate perioperative pain and blunt the stress response to surgery. Proper management of postoperative pain has invariably been shown to reduce the incidence of postoperative complications and accelerate recovery. Neuraxial analgesic techniques after major thoracic and upper abdominal surgery have long been established to reduce respiratory, cardiovascular, metabolic, inflammatory, and neurohormonal complications. The aim of this review is to evaluate and discuss the relevant clinical benefits and outcome, as well as the possibilities and limits of thoracic epidural anesthesia/analgesia (TEA) in the setting of esophageal resections. A comprehensive search of original articles was conducted investigating relevant literature on MEDLINE, Cochrane reviews, Google Scholar, PubMed, and EMBASE from 1985 to July2017. The relationship between TEA and important endpoints such as the quality of postoperative pain control, postoperative respiratory complications, surgical stress-induced immunosuppression, the overall postoperative morbidity, length of hospital stay, and major outcomes has been explored and reported. TEA has proven to enable patients to mobilize faster, cooperate comfortably with respiratory physiotherapists and achieve satisfactory postoperative lung functions more rapidly. The superior analgesia provided by thoracic epidurals compared to that from parenteral opioids may decrease the incidence of ineffective cough, atelectasis and pulmonary infections, while the associated sympathetic block has been shown to enhance bowel blood flow, prevent reductions in gastric conduit perfusion, and reduce the duration of ileus. Epidural anesthesia/analgesia is still commonly used for major ‘open’ esophageal surgery, and the recognized advantages in this setting are soundly established, in particular as regards the early recovery from anesthesia, the quality of postoperative pain control, and the significantly shorter duration of postoperative mechanical ventilation. However, this technique requires specific technical skills for an optimal conduction and is not devoid of risks, complications, and failures.
- 25 February 2017
- Published by Elsevier in Transplantation Reviews
- Vol. 31 (3) , 193-206
Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment
- 25 February 2017
- Published by Elsevier in Transplantation Reviews
- Vol. 31 (3) , 193-206
Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment
- 2 November 2016
- Published by Springer Nature
- p. 37-49
Living-Related Organ Transplantations
- Open Access
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (26) , 8004-13
Perioperative thrombotic complications in liver transplantation
Although the perioperative bleeding complications and the major side effects of blood transfusion have always been the primary concern in liver transplantation (OLT), the possible cohesion of an underestimated intrinsic hypercoagulative state during and after the transplant procedure may pose a major threat to both patient and graft survival. Thromboembolism during OLT is characterized not only by a complex aetiology, but also by unpredictable onset and evolution of the disease. The initiation of a procoagulant process may be triggered by various factors, such as inflammation, venous stasis, ischemia-reperfusion injury, vascular clamping, anatomical and technical abnormalities, genetic factors, deficiency of profibrinolytic activity, and platelet activation. The involvement of the arterial system, intracardiac thrombosis, pulmonary emboli, portal vein thrombosis, and deep vein thrombosis, are among the most serious thrombotic events in the perioperative period. The rapid detection of occlusive vascular events is of paramount importance as it heavily influences the prognosis, particularly when these events occur intraoperatively or early after OLT. Regardless of the lack of studies and guidelines on anticoagulant prophylaxis in this setting, many institutions recommend such an approach especially in the subset of patients at high risk. However, the decision of when, how and in what doses to use the various chemical anticoagulants is still a difficult task, since there is no common consensus, even for high-risk cases. The risk of postoperative thromboembolism causing severe hemodynamic events, or even loss of graft function, must be weighed and compared with the risk of an important bleeding. In this article we briefly review the risk factors and the possible predictors of major thrombotic complications occurring in the perioperative period, as well as their incidence and clinical features. Moreover, the indications to pharmacological prophylaxis and the current treatment strategies are also summarized.
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (26) , 8004-13
Open AccessPerioperative thrombotic complications in liver transplantation
Although the perioperative bleeding complications and the major side effects of blood transfusion have always been the primary concern in liver transplantation (OLT), the possible cohesion of an underestimated intrinsic hypercoagulative state during and after the transplant procedure may pose a major threat to both patient and graft survival. Thromboembolism during OLT is characterized not only by a complex aetiology, but also by unpredictable onset and evolution of the disease. The initiation of a procoagulant process may be triggered by various factors, such as inflammation, venous stasis, ischemia-reperfusion injury, vascular clamping, anatomical and technical abnormalities, genetic factors, deficiency of profibrinolytic activity, and platelet activation. The involvement of the arterial system, intracardiac thrombosis, pulmonary emboli, portal vein thrombosis, and deep vein thrombosis, are among the most serious thrombotic events in the perioperative period. The rapid detection of occlusive vascular events is of paramount importance as it heavily influences the prognosis, particularly when these events occur intraoperatively or early after OLT. Regardless of the lack of studies and guidelines on anticoagulant prophylaxis in this setting, many institutions recommend such an approach especially in the subset of patients at high risk. However, the decision of when, how and in what doses to use the various chemical anticoagulants is still a difficult task, since there is no common consensus, even for high-risk cases. The risk of postoperative thromboembolism causing severe hemodynamic events, or even loss of graft function, must be weighed and compared with the risk of an important bleeding. In this article we briefly review the risk factors and the possible predictors of major thrombotic complications occurring in the perioperative period, as well as their incidence and clinical features. Moreover, the indications to pharmacological prophylaxis and the current treatment strategies are also summarized.
- 3 October 2014
- Vol. 81 (1) , 92-3
Levosimendan in lung transplant recipients with difficult weaning from ECMO.
- 3 October 2014
- Vol. 81 (1) , 92-3
Levosimendan in lung transplant recipients with difficult weaning from ECMO.
- 1 September 2014
- Published by Elsevier in Transplantation Proceedings
- Vol. 46 (7) , 2300-2307
Pain Control After Liver Transplantation Surgery
- 1 September 2014
- Published by Elsevier in Transplantation Proceedings
- Vol. 46 (7) , 2300-2307
Pain Control After Liver Transplantation Surgery
- 1 March 2014
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 31 (3) , 175-176
Transient paraplegia after epidural catheter removal during low molecular heparin prophylaxis
- 1 March 2014
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 31 (3) , 175-176
Transient paraplegia after epidural catheter removal during low molecular heparin prophylaxis